These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9971760)

  • 1. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.
    Gasmi M; Glynn J; Jin MJ; Jolly DJ; Yee JK; Chen ST
    J Virol; 1999 Mar; 73(3):1828-34. PubMed ID: 9971760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.
    Srinivasakumar N; Schuening FG
    J Virol; 1999 Nov; 73(11):9589-98. PubMed ID: 10516068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
    Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
    J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.
    Johnston JC; Gasmi M; Lim LE; Elder JH; Yee JK; Jolly DJ; Campbell KP; Davidson BL; Sauter SL
    J Virol; 1999 Jun; 73(6):4991-5000. PubMed ID: 10233961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A third-generation lentivirus vector with a conditional packaging system.
    Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
    J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector.
    Molina RP; Matukonis M; Paszkiet B; Zhang J; Kaleko M; Luo T
    Virology; 2002 Dec; 304(1):10-23. PubMed ID: 12490399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes.
    Rizvi TA; Lew KA; Murphy EC; Schmidt RD
    Virology; 1996 Oct; 224(2):517-32. PubMed ID: 8874512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rev-free HIV-1 gene delivery system for targeting Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway.
    Srinivasakumar N
    PLoS One; 2011; 6(12):e28462. PubMed ID: 22164294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced mobilization of Rev-responsive element-deficient lentiviral vectors.
    Lucke S; Grunwald T; Uberla K
    J Virol; 2005 Jul; 79(14):9359-62. PubMed ID: 15994835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.